Pure Global

In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study - Trial UMIN000048054

Access comprehensive clinical trial information for UMIN000048054 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sato Pharmaceutical Co., Ltd and is currently Recruiting. The study focuses on Onychomycosis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048054
Not Applicable
Recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000048054
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study

Study Focus

Onychomycosis

Observational

Sponsor & Location

Sato Pharmaceutical Co., Ltd

Japan

Timeline & Enrollment

Not Applicable

Mar 29, 2022

N/A

ICD-10 Classifications

Onychogryphosis
Chromomycosis, unspecified
Onycholysis
Actinomycosis
Blastomycosis

Data Source

University Hospital Medical Information Network

UMIN000048054

Non-Device Trial